About this trial
This clinical trial evaluates the usefulness of a self-monitoring platform for tracking medication safety events and concerns in patients with lung, colorectal, breast, and prostate cancer. Patients receiving oral anticancer agents often encounter challenges in managing complex treatment regimens, potentially life-threatening toxicities, and drug-drug and drug-food interactions at home. To achieve the goal of medication safety, they need to become "vigilant partners" in medication and toxicity self-monitoring, including timely reporting of medication events to clinicians when their care transitions back home. In this study, patients use an online self-monitoring platform to track their experiences or concerns about taking their medications, including their experiences with symptoms. This platform may be a useful way for patients to track problems they have when taking their medications at home and may help them take better care of their health.
Eligibility criteria
Qualifiers
Participants are adult patients (aged 18 years or older)
Diagnosed with lung, colorectal, breast, or prostate cancer
Are currently receiving active cancer treatments
Are self-managing one or more prescribed cancer medications
Disqualifiers
Can't access technology or do not use technology
Do not have access to the internet
Do not speak or read English
Not permitted to participate by their health care providers
Trial design
Treatments tested in this trial
- Educational Intervention
- Electronic Health Record Review
- Follow-Up
- Internet-Based Intervention
- Interview
- Survey Administration
Treatment groups
Locations
1Sponsors and collaborators
University of Michigan Rogel Cancer Center
Lead sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborator